<SEC-DOCUMENT>0001013762-23-006993.txt : 20231026
<SEC-HEADER>0001013762-23-006993.hdr.sgml : 20231026
<ACCEPTANCE-DATETIME>20231026172012
ACCESSION NUMBER:		0001013762-23-006993
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20231026
DATE AS OF CHANGE:		20231026
EFFECTIVENESS DATE:		20231026

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADIAL PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001513525
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				800667150
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-495746
		FILM NUMBER:		231351194

	BUSINESS ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901
		BUSINESS PHONE:		434-422-9800

	MAIL ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20170515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20110218
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0708</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001513525</cik>
        <entityName>ADIAL PHARMACEUTICALS, INC.</entityName>
        <issuerAddress>
            <street1>1180 SEMINOLE TRAIL, SUITE 495</street1>
            <city>CHARLOTTESVILLE</city>
            <stateOrCountry>VA</stateOrCountry>
            <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
            <zipCode>22901</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>(434) 422-9800</issuerPhoneNumber>
        <jurisdictionOfInc>DELAWARE</jurisdictionOfInc>
        <issuerPreviousNameList>
            <previousName>Adial Pharmaceuticals L.L.C.</previousName>
        </issuerPreviousNameList>
        <edgarPreviousNameList>
            <previousName>ADial Pharmaceuticals, L.L.C.</previousName>
            <previousName>Adial Pharmaceuticals, L.L.C.</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Cary</firstName>
                <middleName>J.</middleName>
                <lastName>Claiborne</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22902</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Joseph</firstName>
                <middleName>M.</middleName>
                <lastName>Truluck</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22901</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>James</firstName>
                <middleName>K.</middleName>
                <lastName>Anderson</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22901</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Robertson</firstName>
                <middleName>H.</middleName>
                <lastName>Gilliland</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22901</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Bankole</firstName>
                <middleName>A.</middleName>
                <lastName>Johnson</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22901</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>James</firstName>
                <middleName>W.</middleName>
                <lastName>Newman, Jr.</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22901</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Kevin</firstName>
                <lastName>Schuyler, CFA</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22901</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Tony</firstName>
                <lastName>Goodman</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1180 Seminole Trail, Suite 495</street1>
                <city>Charlottesville</city>
                <stateOrCountry>VA</stateOrCountry>
                <stateOrCountryDescription>VIRGINIA</stateOrCountryDescription>
                <zipCode>22901</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Pharmaceuticals</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06b</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2023-10-19</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
            <isSecurityToBeAcquiredType>true</isSecurityToBeAcquiredType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse>The Company issued pre-funded warrants, series A warrants and series B warrants , each warrant to purchase one share of common stock</clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList>
            <recipient>
                <recipientName>H.C. Wainwright &amp; Co., LLC</recipientName>
                <recipientCRDNumber>375</recipientCRDNumber>
                <associatedBDName>None</associatedBDName>
                <associatedBDCRDNumber>None</associatedBDCRDNumber>
                <recipientAddress>
                    <street1>430 PARK AVENUE</street1>
                    <city>NEW YORK</city>
                    <stateOrCountry>NY</stateOrCountry>
                    <stateOrCountryDescription>NEW YORK</stateOrCountryDescription>
                    <zipCode>10022</zipCode>
                </recipientAddress>
                <statesOfSolicitationList>
                    <state>NY</state>
                    <description>NEW YORK</description>
                </statesOfSolicitationList>
                <foreignSolicitation>false</foreignSolicitation>
            </recipient>
        </salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>3998582</totalOfferingAmount>
            <totalAmountSold>3998582</totalAmountSold>
            <totalRemaining>0</totalRemaining>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>true</hasNonAccreditedInvestors>
            <numberNonAccreditedInvestors>0</numberNonAccreditedInvestors>
            <totalNumberAlreadyInvested>1</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>320000</dollarAmount>
                <isEstimate>true</isEstimate>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse>Includes placement agent  fee of 7% &amp; management fee of 1% of the aggregate gross proceeds of the offering. The issuer issued to placement agent designees warrants to purchase up to 85,106 shares at an exercise price of $3.25 and paid offering expenses</clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
                <isEstimate>true</isEstimate>
            </grossProceedsUsed>
            <clarificationOfResponse>While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers.</clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>ADIAL PHARMACEUTICALS, INC.</issuerName>
                <signatureName>/s/ Cary J. Claiborne</signatureName>
                <nameOfSigner>Cary J. Claiborne</nameOfSigner>
                <signatureTitle>Chief Executive Officer</signatureTitle>
                <signatureDate>2023-10-26</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
